VIRBAC SA (VIRP.PA) Fundamental Analysis & Valuation

EPA:VIRP • FR0000031577

Current stock price

349 EUR
-6.5 (-1.83%)
Last:

This VIRP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. VIRP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year VIRP was profitable.
  • In the past year VIRP had a positive cash flow from operations.
  • Each year in the past 5 years VIRP has been profitable.
  • VIRP had a positive operating cash flow in each of the past 5 years.
VIRP.PA Yearly Net Income VS EBIT VS OCF VS FCFVIRP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • VIRP has a Return On Assets of 7.88%. This is in the better half of the industry: VIRP outperforms 60.78% of its industry peers.
  • VIRP has a Return On Equity of 13.41%. This is comparable to the rest of the industry: VIRP outperforms 56.86% of its industry peers.
  • VIRP has a Return On Invested Capital of 11.43%. This is in the better half of the industry: VIRP outperforms 60.78% of its industry peers.
Industry RankSector Rank
ROA 7.88%
ROE 13.41%
ROIC 11.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VIRP.PA Yearly ROA, ROE, ROICVIRP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 10.30%, VIRP perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • VIRP's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 15.71%, VIRP perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of VIRP has grown nicely.
  • VIRP's Gross Margin of 66.58% is in line compared to the rest of the industry. VIRP outperforms 43.14% of its industry peers.
  • VIRP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.71%
PM (TTM) 10.3%
GM 66.58%
OM growth 3Y1.33%
OM growth 5Y3.81%
PM growth 3Y0.9%
PM growth 5Y-6.69%
GM growth 3Y13.46%
GM growth 5Y6.47%
VIRP.PA Yearly Profit, Operating, Gross MarginsVIRP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. VIRP.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), VIRP is creating some value.
  • There is no outstanding debt for VIRP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VIRP.PA Yearly Shares OutstandingVIRP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VIRP.PA Yearly Total Debt VS Total AssetsVIRP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • VIRP has an Altman-Z score of 4.48. This indicates that VIRP is financially healthy and has little risk of bankruptcy at the moment.
  • VIRP has a Altman-Z score of 4.48. This is in the better half of the industry: VIRP outperforms 66.67% of its industry peers.
  • VIRP has a debt to FCF ratio of 2.98. This is a good value and a sign of high solvency as VIRP would need 2.98 years to pay back of all of its debts.
  • The Debt to FCF ratio of VIRP (2.98) is better than 68.63% of its industry peers.
  • A Debt/Equity ratio of 0.16 indicates that VIRP is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.16, VIRP belongs to the top of the industry, outperforming 80.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.98
Altman-Z 4.48
ROIC/WACC1.43
WACC7.97%
VIRP.PA Yearly LT Debt VS Equity VS FCFVIRP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that VIRP should not have too much problems paying its short term obligations.
  • VIRP has a Current ratio (1.53) which is in line with its industry peers.
  • A Quick Ratio of 0.80 indicates that VIRP may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.80, VIRP is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.8
VIRP.PA Yearly Current Assets VS Current LiabilitesVIRP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. VIRP.PA Growth Analysis

3.1 Past

  • VIRP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.79%.
  • VIRP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.23% yearly.
  • The Revenue has been growing slightly by 4.82% in the past year.
  • The Revenue has been growing by 9.41% on average over the past years. This is quite good.
EPS 1Y (TTM)3.79%
EPS 3Y7.64%
EPS 5Y2.23%
EPS Q2Q%1335.35%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.39%
Revenue growth 5Y9.41%
Sales Q2Q%4.64%

3.2 Future

  • Based on estimates for the next years, VIRP will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.28% on average per year.
  • The Revenue is expected to grow by 5.98% on average over the next years.
EPS Next Y13.5%
EPS Next 2Y11.93%
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue Next Year6.01%
Revenue Next 2Y5.84%
Revenue Next 3Y5.46%
Revenue Next 5Y5.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIRP.PA Yearly Revenue VS EstimatesVIRP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
VIRP.PA Yearly EPS VS EstimatesVIRP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

4

4. VIRP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.39, VIRP is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of VIRP is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of VIRP to the average of the S&P500 Index (24.88), we can say VIRP is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 16.21 indicates a correct valuation of VIRP.
  • 64.71% of the companies in the same industry are more expensive than VIRP, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. VIRP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.39
Fwd PE 16.21
VIRP.PA Price Earnings VS Forward Price EarningsVIRP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VIRP indicates a somewhat cheap valuation: VIRP is cheaper than 68.63% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VIRP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.23
EV/EBITDA 10.8
VIRP.PA Per share dataVIRP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VIRP's earnings are expected to grow with 13.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.44
PEG (5Y)8.71
EPS Next 2Y11.93%
EPS Next 3Y13.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. VIRP.PA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.41%, VIRP is not a good candidate for dividend investing.
  • VIRP's Dividend Yield is comparable with the industry average which is at 1.89.
  • With a Dividend Yield of 0.41, VIRP pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
VIRP.PA Yearly Dividends per shareVIRP.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • VIRP pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y11.93%
EPS Next 3Y13.28%
VIRP.PA Yearly Income VS Free CF VS DividendVIRP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M
VIRP.PA Dividend Payout.VIRP.PA Dividend Payout, showing the Payout Ratio.VIRP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

VIRP.PA Fundamentals: All Metrics, Ratios and Statistics

VIRBAC SA

EPA:VIRP (3/27/2026, 7:00:00 PM)

349

-6.5 (-1.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-17
Earnings (Next)04-16
Inst Owners25.55%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap2.93B
Revenue(TTM)1.46B
Net Income(TTM)150.89M
Analysts82.5
Price Target417.95 (19.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.28%
EPS NY rev (3m)1.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE 19.39
Fwd PE 16.21
P/S 2
P/FCF 30.23
P/OCF 14.71
P/B 2.6
P/tB 5.44
EV/EBITDA 10.8
EPS(TTM)18
EY5.16%
EPS(NY)21.53
Fwd EY6.17%
FCF(TTM)11.54
FCFY3.31%
OCF(TTM)23.72
OCFY6.8%
SpS174.57
BVpS134.11
TBVpS64.13
PEG (NY)1.44
PEG (5Y)8.71
Graham Number233.06
Profitability
Industry RankSector Rank
ROA 7.88%
ROE 13.41%
ROCE 16.46%
ROIC 11.43%
ROICexc 12.57%
ROICexgc 23.33%
OM 15.71%
PM (TTM) 10.3%
GM 66.58%
FCFM 6.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.33%
OM growth 5Y3.81%
PM growth 3Y0.9%
PM growth 5Y-6.69%
GM growth 3Y13.46%
GM growth 5Y6.47%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.98
Debt/EBITDA 0.6
Cap/Depr 168.58%
Cap/Sales 6.97%
Interest Coverage 53.91
Cash Conversion 68.44%
Profit Quality 64.19%
Current Ratio 1.53
Quick Ratio 0.8
Altman-Z 4.48
F-Score6
WACC7.97%
ROIC/WACC1.43
Cap/Depr(3y)144.88%
Cap/Depr(5y)133.01%
Cap/Sales(3y)5.84%
Cap/Sales(5y)5.27%
Profit Quality(3y)81.35%
Profit Quality(5y)70.88%
High Growth Momentum
Growth
EPS 1Y (TTM)3.79%
EPS 3Y7.64%
EPS 5Y2.23%
EPS Q2Q%1335.35%
EPS Next Y13.5%
EPS Next 2Y11.93%
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.39%
Revenue growth 5Y9.41%
Sales Q2Q%4.64%
Revenue Next Year6.01%
Revenue Next 2Y5.84%
Revenue Next 3Y5.46%
Revenue Next 5Y5.98%
EBIT growth 1Y0.49%
EBIT growth 3Y7.81%
EBIT growth 5Y13.58%
EBIT Next Year41.04%
EBIT Next 3Y19.75%
EBIT Next 5Y14.53%
FCF growth 1Y-46.61%
FCF growth 3Y28.73%
FCF growth 5Y1.5%
OCF growth 1Y-24%
OCF growth 3Y26.21%
OCF growth 5Y10.85%

VIRBAC SA / VIRP.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VIRBAC SA (VIRP.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA.


What is the valuation status of VIRBAC SA (VIRP.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for VIRBAC SA?

VIRBAC SA (VIRP.PA) has a profitability rating of 5 / 10.


Can you provide the financial health for VIRP stock?

The financial health rating of VIRBAC SA (VIRP.PA) is 5 / 10.


Can you provide the expected EPS growth for VIRP stock?

The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 13.5% in the next year.